Evidence map›Paper›PMID 41251350›Full record

ArticleJournal of virology2025

TRIM29 inhibits PRRSV replication by targeting nsp11 for degradation.

Wei Wen, Zhenghong Xue, Yi Lu, Yuhang Liu, Wenqiang Wang, Zhenbang Zhu, Xiangdong Li

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Biomolecules · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wei WenJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.ORCID 0000-0002-4059-5358
Zhenghong XueJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.
Yi LuJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.
Yuhang LiuJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.
Wenqiang WangJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.
Zhenbang ZhuJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.
Xiangdong LiJiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou, People's Republic of China.ORCID 0000-0002-4635-1602

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ubiquitination plays critical roles in viral infections. This study demonstrates that porcine reproductive and respiratory syndrome virus (PRRSV) endoribonuclease nsp11 undergoes K48-linked polyubiquitination specifically at the conserved catalytic residue lysine 173 (K173) during viral infection. This modification targets nsp11 for degradation via the ubiquitin-proteasome system (UPS), as evidenced by the profound stabilization of a ubiquitination-deficient K173R mutant. Remarkably, this ubiquitination mechanism targeting the endonuclease active site is evolutionarily conserved across most arteriviruses, including simian hemorrhagic fever virus and equine arteritis virus, with mouse lactate dehydrogenase-elevating virus being an exception. We further identify the host E3 ubiquitin ligase TRIM29 as a key regulator that binds PRRSV nsp11 via its coiled-coil domain and specifically promotes its K48-linked ubiquitination and subsequent proteasomal degradation. TRIM29-mediated degradation of nsp11 counteracts nsp11's suppression of interferon (IFN-β) and interferon-stimulated gene production. Consequently, TRIM29 significantly inhibits PRRSV replication. Collectively, these findings uncover a conserved UPS-mediated regulatory mechanism targeting a critical arteriviral endonuclease and demonstrate TRIM29 as a potent host restriction factor that antagonizes PRRSV immune evasion by degrading nsp11.IMPORTANCEThis study reveals that porcine reproductive and respiratory syndrome virus (PRRSV) nsp11 undergoes K48-linked polyubiquitination at catalytic residue K173, triggering ubiquitin-proteasome system (UPS)-mediated degradation, a mechanism conserved in most arteriviruses. The host E3 ligase TRIM29 binds nsp11 via its coiled-coil domain, catalyzing this ubiquitination to degrade nsp11. This counteracts nsp11's suppression of interferon (IFN-β)/interferon-stimulated gene production and inhibits PRRSV replication. These findings identify TRIM29 as a key host restriction factor that disrupts viral immune evasion by targeting a conserved arteriviral endonuclease via the UPS.

Indexed as

DNA-Binding ProteinsPorcine Reproductive and Respiratory SyndromePorcine respiratory and reproductive syndrome virusTranscription FactorsViral Nonstructural ProteinsVirus ReplicationAnimalsCell LineHEK293 CellsHumansProteasome Endopeptidase ComplexProteolysisSwineUbiquitinUbiquitinationUbiquitin-Protein LigasesDNA-Binding ProteinsProteasome Endopeptidase ComplexTranscription FactorsUbiquitinUbiquitin-Protein LigasesViral Nonstructural Proteinsendonuclease activity sitensp11proteasome degradationPRRSVTRIM29

Identifiers

PMID41251350
PMCPMC12724275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.